The brachytherapy device market is expanding as cancer prevalence rises and healthcare providers seek more targeted radiation-treatment options. The market was valued at USD 5.98 billion in 2024 and is projected to reach USD 8.5 billion by 2032, growing at a CAGR of 4.49%. 1035

Brachytherapy is a form of internal radiation therapy in which radioactive sources are placed near or within a treatment area. It is used in selected oncology settings to deliver focused radiation while aiming to limit exposure to surrounding healthy tissue. Treatment planning, device selection, and patient suitability are determined by specialized oncology and radiation-therapy teams.

Cancer treatment is the largest application segment, valued at USD 3.7 billion in 2024 and projected to reach USD 5.2 billion by 2032. Brachytherapy can be used in treatment pathways for several cancers, including prostate, breast, cervical, and other localized tumors, depending on clinical guidelines and patient characteristics.

High-dose-rate brachytherapy devices are important because they can deliver radiation over shorter treatment periods. Low-dose-rate devices remain relevant for therapies that require more continuous radiation exposure over time. Electronic brachytherapy systems are gaining attention because they offer controlled delivery and may reduce some source-handling requirements.

Hospitals are the largest end users because brachytherapy requires specialized radiation-oncology infrastructure, imaging systems, treatment planning, radiation-safety protocols, and multidisciplinary clinical teams. Specialty clinics and cancer research institutions also play important roles in innovation and treatment delivery.

Technological progress is improving treatment precision. Real-time imaging, computer-assisted planning, miniaturized devices, AI-supported dose planning, and improved applicator systems can help clinicians tailor therapy more closely to tumor location and individual anatomy.

North America leads the market, while Asia-Pacific is expected to grow quickly as cancer-care capacity, radiation-oncology infrastructure, and healthcare investment expand.

Read more: Brachytherapy Device Market

FAQs

Q1. What is brachytherapy?
It is a type of internal radiation therapy used in selected cancer-treatment settings.

Q2. Which application leads the brachytherapy device market?
Cancer treatment leads because brachytherapy is widely used for focused radiation delivery in oncology.

Tags: brachytherapy devices, internal radiation therapy, cancer treatment, radiation oncology, high-dose-rate brachytherapy